SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.350.0%Nov 7 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (1127)11/23/2001 8:02:50 AM
From: smh  Read Replies (1) of 1475
 
<He did propose "four major approaches to preventing such cases in the future: (1) greater purification of stem cells (to eliminate contaminating tumor cells), (2) aggressive screening of donors (though this donor was asymptomatic at the time of donation), (3) if donors develop tumors, design sensitive tumor-specific assays to screen transplant recipients, and (4) develop better assays to test for such clones." >

TD,

I think he forgot a fifth alternative, which arguably should be number 1 on the list... (5) universal preservation of cord blood stem cells.

Disclosure; I own some CCEL; I own a lot of BTRN.

SMH
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News